SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?


To: arnie h who wrote (1557)1/10/1999 2:17:00 PM
From: Rudy Saucillo  Read Replies (1) | Respond to of 2173
 
My comment was in reference to my amazement that people still follow, much less *buy*, on Murphy's recs. In regards to pramlintide, it's clearly dead as a drug candidate. No company will buy Amylin to plow more money into pramlintide trials. I'm interested in what remains of Amylin's technology, but don't currently have a strong opinion. Rudy